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Despite the development of numerous gene regulatory network (GRN) inference methods
in the last years, their application, usage and the biological significance of the resulting
GRN remains unclear for our general understanding of large-scale gene expression data
in routine practice. In our study, we conduct a structural and a functional analysis of B-cell
lymphoma GRNs that were inferred using 3 mutual information-based GRN inference
methods: C3Net, BC3Net and Aracne. From a comparative analysis on the global level,
we find that the inferred B-cell lymphoma GRNs show major differences. However,
on the edge-level and the functional-level—that are more important for our biological
understanding—the B-cell lymphoma GRNs were highly similar among each other. Also,
the ranks of the degree centrality values and major hub genes in the inferred networks are
highly conserved as well. Interestingly, the major hub genes of all GRNs are associated
with the G-protein-coupled receptor pathway, cell-cell signaling and cell cycle. This implies
that hub genes of the GRNs can be highly consistently inferred with C3Net, BC3Net, and
Aracne, representing prominent targets for signaling pathways. Finally, we describe the
functional and structural relationship between C3Net, BC3Net and Aracne gene regulatory
networks. Our study shows that these GRNs that are inferred from large-scale gene
expression data are promising for the identification of novel candidate interactions and
pathways that play a key role in the underlying mechanisms driving cancer hallmarks.
Overall, our comparative analysis reveals that these GRNs inferred with considerably
different inference methods contain large amounts of consistent, method independent,
biological information.
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1. INTRODUCTION
To date, a vast amount of gene regulatory network (GRN) infer-
encemethods are being developed with the future goal to establish
qualitative and quantitative procedures for a structural, biological
and experimental validation of the inferred networks (Friedman,
2004;Wille et al., 2004;Werhli et al., 2006;Margolin and Califano,
2007; Yip et al., 2010; Zhang et al., 2011; Emmert-Streib et al.,
2012). One of the most conservative approaches for GRN infer-
ence was introduced with the C3Net (Altay and Emmert-Streib,
2010, 2011) method that inferres at most one interaction (edge)
for each gene with the strongest mutual dependency. An exten-
sion of C3Net was introduced by the bagging (Breiman, 1996;
Zhang and Singer, 2010) approach BC3Net (de Matos Simoes
and Emmert-Streib, 2012) that allows to aggregate ensembles
of C3Net networks that are inferred from bootstrap (Efron and
Tibshirani, 1994; Davison and Hinkley, 1997) datasets. The main
advantage of a C3Net and BC3Net over many other methods
is the intuitive interpretation of the inferred interactions that
correspond to gene-pairs with the strongest significant mutual
dependency, present in the data. Notably, a C3Net GRN has
the property to infer very sparse, modular networks with a
preference for interactions in the periphery of the network
corresponding to genes with a less complex mutual dependency
structure.
In de Matos Simoes and Emmert-Streib (2011), C3Net was
used to infer GRNs from simulated gene expression data using
a known underlying network structure. This study demonstrated
that interactions (edges) of genes with a low number of direct
neighbors (low degree) are more likely to be inferred correctly
compared to interactions of genes with a large number of direct
neighbors. From this observation one can presume that the
interaction periphery of the unknown gene network is more
prominently represented in an inferred GRN due to the lower
complexities of the gene expression dependencies between the
genes. However, the underlying gene network is unknown when a
GRN is inferred from real biological gene expression data. Thus,
the periphery and the center of the gene network is restricted to
known experimental interactions that provide only a static and
incomplete representation of the gene network. Furthermore, in
de Matos Simoes et al. (2012) it was shown that the giant con-
nected component (GCC) of the GRN using C3Net is highly
enriched with membrane associated proteins. This observation
suggested that the periphery of a gene network represents, to
some extend, also the physical periphery of the biological cell that
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Network Inference
• Q: What types of biological networks have been inferred in the paper?
• A: We use gene expression data from B-cell lymphoma and infer GRNs.
• Q: How was the quality/utility of the inferred networks assessed?
• A:We compare the inferred GRNs with a protein-protein interaction network and a transcriptional regulatory network.
Furthermore, we compare 3 GRNs among each other to identify their similarity. This analysis is conducted by using
the Gene Ontology database and a variety of additional databases.
• Q: How were these networks validated?
• A: All networks are analyzed computationally and statistical hypotheses testing is employed to test various
hypotheses about the network structure and the biological function of the investigated GRNs.
is centered around signaling receptors that represent the major
hubs of the GRN.
When comparing different methods with each other for infer-
ring GRN it is important to conduct this comparison on sim-
ilar grounds. For this reason, we are comparing in this paper
only methods with each other that employ statistical hypothe-
sis testing (Lehman, 2005; Young and Smith, 2005) and utilizing
mutual information to estimate the interactions within regula-
tory networks. In this way we are avoiding a potential bias that
could result from comparisons between networks with a different
meaning.
The performance of GRN inference methods have been often
compared using simulated data from biological or simulated net-
work structures (Van den Bulcke et al., 2006; Schaffter et al., 2011;
Emmert-Streib, 2013). One major problem with a simulation-
based analysis is that the assumed mechanisms to simulate gene
expression are only partially understood biologically, leaving a
certain uncertainty about the resulting properties of the expres-
sion data. On the other hand, when real data are used, the under-
lying network structure remains unknown or highly incomplete.
Furthermore, differences between inferred GRN using different
methods may be negligible due to small sample sizes of real data
sets and the presence of noise in these gene expression data.
Of great importance is the question “what” and “how con-
sistent” is the information that can be extracted from a given
large-scale gene expression data set to generate novel data-driven
hypotheses. Unfortunately, to date, frequently, targets for wetlab
studies are chosen based on the popularity of key genes rather
than on the information within data sets. However, a non-data
driven hypothesis ignores the limitations of an underlying data set
to resolve known and unknown gene relationships. Furthermore,
the efforts that have been performed for the validation of GRNs
where mostly focusing on individual interactions, such as tran-
scription factor target gene interactions (e.g., for MYC). To our
knowledge, the most prominent genes appearing in a GRN, e.g.,
the actual hub genes, have not been considered for experimental
validation.
In our study, we infer a C3Net, BC3Net and Aracne B-cell lym-
phoma GRN from a large-scale gene expression data set (Basso
et al., 2005). We provide a structural and a functional com-
parison between the sparse, modular network structure inferred
by C3Net and the more densely connected BC3Net and Aracne
GRNs. Furthermore, we discuss the role of the hub genes and
known cancer genes, such as MYC, we find in the inferred GRNs.
The paper is organized as follows. In the next section, we
discuss the data we use for our analysis, the network inference
methods and statistical measures we use for our analysis. In the
results section, we present a comparative analysis and discuss dif-
ferences between the 3 inferred GRNs and 2 reference networks (a
PPN and a TRN). This article finishes with a discussion.
2. MATERIALS AND METHODS
2.1. GENE EXPRESSION DATA
For our study, we use the gene expression data with the GEO
(Barrett et al., 2011) accession GSE2350 from Basso et al. (2005).
The data set includes transformed and untransformed B-cell lym-
phoma samples. For our analysis, we consider only samples for
which raw gene expression data in form of Affymetrix CEL files
are available. From the total of 387 samples of the GSE2350
dataset, 344 samples were available in a CEL file format from the
hgu95a and hgu95av2 chip platform. The data were preprocessed
as described in detail in de Matos Simoes and Emmert-Streib
(2011). Probeset identifiers were mapped to entrez gene symbols
when available using the org.Hs.eg.db R-package (Carlson, 2013).
Multiple probesets that mapped to the same gene were summa-
rized using their median value. The final gene expression data set
comprises 9684 genes and 344 samples. We subsequently applied
a copula transformation to the processed gene expression data, as
described in Margolin et al. (2006).
2.2. INFERENCE OF GENE REGULATORY NETWORKS
For the inference of the B cell lymphoma GRN, we use 3 mutual
information-based GRN inference methods: C3Net, BC3Net and
Aracne (Margolin et al., 2006; Altay and Emmert-Streib, 2010;
de Matos Simoes and Emmert-Streib, 2012). Mutual information
(MI) for all gene pairs is computed using a Pearson estimator
(Meyer et al., 2007; Olsen et al., 2009),
I (X,Y) = −1
2
log
(
1 − ρ2) , (1)
where ρ is the Pearson correlation coefficient.
2.2.1. Null-distribution of mutual information values
In order to determine the statistical significance of the mutual
information values between genes we test for each pair of genes
the following null hypothesis.
HI0 : The mutual information between gene i and j is zero.
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Because we are using a nonparametric test we need to obtain the
corresponding null distribution for HI0 from a randomization of
the data. Principally, there are several ways to perform such a ran-
domization. Here we permute the sample and gene labels for all
genes of the entire expression matrix at once. In de Matos Simoes
and Emmert-Streib (2011) we investigated three different ran-
domization schemes and found that the randomization proce-
dure applied here [in deMatos Simoes and Emmert-Streib (2011)
called RM3] leads to similar results as other procedures that are
computationally more demanding.
2.2.2. C3Net
The C3Net (Conservative Causal Core) algorithm consists of
three main steps (Altay and Emmert-Streib, 2010, 2011). In
the first step, mutual information values among all gene pairs
are estimated. For this, we use a Pearson estimator for mutual
information values, as given in Equation 1. In the second
step, we select for each gene only the largest mutual informa-
tion interaction (see Figure 1, indicated by the red elements in
matrix I). This interaction corresponds also to the most sig-
nificant gene among the neighbor edges. Third, we apply a
non-parametric significance test for the mutual information val-
ues of the largest elements. The null distribution for this test
is obtained from a randomization of the sample labels in the
gene expression matrix. We use a significance level of α = 0.05
in combination with a Bonferroni multiple testing correction
(Dudoit and van der Laan, 2007).
Since C3Net employs mutual information values as test statis-
tics among genes, there is no directional information that can
be inferred thereof. Hence, the resulting network GC3Net is undi-
rected and unweighted (corresponding to a symmetric, binary
adjacency matrix A; as indicated by the orange and yellow ele-
ments in Figure 1). For a detailed explanation of C3Net and its
technical details, the reader is referred to Altay and Emmert-Streib
(2010, 2011).
2.2.3. BC3Net
The BC3Net (de Matos Simoes and Emmert-Streib, 2012) algo-
rithm is a bagging (Breiman, 1996) version of C3Net (Altay and
Emmert-Streib, 2010, 2011). Briefly, BC3Net consists of 2 major
steps. In the first step, a bootstrap ensemble of B data sets is
generated. For each data set in the ensemble a GRN is inferred
using C3Net; see Figure 1. In step two, the resulting ensemble
of networks is combined into a weighted network, where the
weights in this network Gweighted describe the ensemble con-
sensus rate for an edge in the bootstrap ensemble. Then, we
apply a binomial test to all edges in the weighted network and
retain only edges that are statistically significance for a signifi-
cance level of α = 0.05 that pass a Bonferroni multiple testing
correction (see Figure 1B—aggregation). This results into the
final network GBC3Net. For a statistically detailed description, the
reader is referred to de Matos Simoes and Emmert-Streib (2012).
2.2.4. Aracne
The Aracne (algorithm for the reconstruction of accurate cellu-
lar networks) algorithm (Basso et al., 2005; Margolin et al., 2006)
consists of two main steps. In step one, it estimates the mutual
information values between all gene pairs and identifies their sta-
tistical significance. In Figure 1, these elements are represented
as green elements in the matrix I′. In step two, all gene-triples
(ijk), i.e., three genes with significant mutual information val-
ues, are used in combination with the data processing inequality
(DPI) (Cover and Thomas, 1991) for thinning the resulting net-
work. Specifically, for each triplet (ijk), the edge corresponding
to the lowest mutual information value I1 = Ii′j′ , with (i′j′) =
argmin{Iij, Ijk, Iik}, is eliminated from the mutual information
matrix I (in Figure 1 indicated by the white circles) and the adja-
cency matrix A, if it is smaller than the second smallest mutual
information value I2, adjusted by a factor (1 − ), i.e.,
Ai′j′ = Aj′i′ =
{
0 Ii′j′ ≤ I2 (1 − )
1 otherwise.
(2)
Here 0 ≤  ≤ 1. The introduction of this step has been moti-
vated by the so called data processing inequality (DPI) (Cover
and Thomas, 1991). The DPI is a relation between mutual infor-
mation values, which means loosely that a post-processing of
data cannot increase its information content. Specifically, one can
show (Cover and Thomas, 1991) that the DPI for the following
relation between the three random variables,
X → Y → Z, (3)
implies that I(X,Z) ≤ I(X,Y). Due to the fact that the criteria in
Equation 2 is for  > 0 less stringent than the DPI (Equation 3),
 is called tolerance parameter.
In order to ensure an unique solution that is independent
of the order of the selected gene-triples, the procedure starts by
listing all possible gene-triplets that can be found from the signif-
icant mutual information values after step one. Then, all of these
gene-triplets are tested sequentially. Hence, the results of these
tests have no influence on subsequent tests and the formation of
gene-triplets.
For our practical application of Aracne, we use the stan-
dalone java executable Aracne2 (Basso et al., 2005; Margolin et al.,
2006) available from (http://wiki.c2b2.columbia.edu/califanolab/
index.php/Software/Aracne) to infer a GRN. For Aracne, we use
the recommended parameter settings for this data set, listed in
the following: For the mutual information estimator a kernel
width of w = 0.12918 is defined with b = 6 bins. The significance
threshold for MI was t = 0.064394 with a p-value threshold of
p = 1.0e − 7. Aracne considers the removal of indirect interac-
tions between a triplet of genes by applying the data processing
inequality (DPI) with a tolerance parameter that is set to  = 0.15.
2.3. EXPERIMENTAL INTERACTIONS: REFERENCE NETWORKS
We use a meta collection of protein-protein interactions provided
by iRefIndex (Razick et al., 2008). iRefIndex gathers protein inter-
actions from BIND, BioGrid, DIP, HPRD, IntAct, MINT, MPact,
MPPI and OPHID. Uniprot and refseq Ids were converted to
entrez gene symbols using the org.Hs.eg.db R package (Carlson,
2013). If an identifier could not be mapped directly to entrez
identifiers, the HUGO gene symbol was used. The remaining
identifiers that could not be directly mapped to entrez gene sym-
bols were not used. The resulting undirected protein network we
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A
B
C
FIGURE 1 | Overview of the 3 applied inference methods and their key methodological analysis steps. (A) C3Net, (B) BC3Net and (C) Aracne.
use for our analysis includes a total of 185, 433 protein-protein
interactions for 15, 233 proteins.
Furthermore, we use a transcriptional regulatory network
(TRN) provided by the HTRidb database comprising a collec-
tion of experimentally validated transcription factor target gene
interactions (Bovolenta et al., 2012). The database comprises a
total of 51, 871 interactions for 284 transcription factors, regulat-
ing 18, 302 genes.
In the results section, we use these two experimental networks
as reference networks to compare them with the inferred GRNs.
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2.4. NETWORK CENTRALITY MEASURES
In the following, we describe 4 network-based measures we use
for our analysis, namely, (A) degree centrality, (B) edge den-
sity, (C) transitivity and (D) assortativity. For a more detailed
description see (Newman, 2010; Emmert-Streib and Dehmer,
2011).
The (A) degree centrality is defined as the total number of
direct neighbors of a vertex vi (gene). Formally, the degree cen-
trality of vi in an undirected network is given by Newman (2010),
C1(vi) =
n∑
j= 1
Aij, (4)
where the adjacency matrix of the network is given by A and n is
the total number of genes. That means C1(vi) of node vi is just
the number of connections that node vi has to other nodes in the
network. Frequently, this is briefly called the degree of a node.
The (B) edge density of a network is the number of edges
divided by the maximal number of possible edges. For an undi-
rected network, this number of possible edges is given by n(n −
1)/2, whereas n is the total number of genes. Hence, the edge den-
sity is a global measure for the connectivity of a network, whereas
small values indicate sparsely connected networks and high values
indicate densely connected networks.
The (C) transitivity centrality value of a vertex vi, also called
the local clustering coefficient, measures the proportion of edges
of the direct neighbors of vi in a clique of k vertices. The local
clustering coefficient is given by Watts and Strogatz (1998),
C3(vi) = 2|{eij}|
k(k − 1) , (5)
where |{eij}| is the number of edges for vertex vi to all its direct
neighbors vj, and
k(k− 1)
2 corresponds to the total number of edges
in a clique of k vertices. Formally, the transitivity of a vertex is that
probability that two neighbors of this vertex are connected with
each other. Informally, this can be translated in “friends of mine
are friends too,” if a “friend” is defined as “connected with.”
Finally, the (D) assortativity measure is the Pearson correlation
coefficient of the degree centrality between the connected vertices
in a network (Newman, 2002),
r = M
−1∑
i jiki −
[
M−1
∑
i
1
2 (ji + ki)
]2
M−1
∑
i
1
2
(
j2i + k2i
)− [M−1∑i 12 (ji + ki)]2
. (6)
Here ji and ki correspond to the degrees of the vertices at the end
of edge i, and M is the total number of edges in the network. We
would like to remark that Equation 6 is symmetric in ji and ki.
Informally, the assortativity is a global measure that gives positive
values when—in average—vertices connect to other vertices that
have a similar degree (e.g., high to high and low to low), and it
has negative values—in average—when vertices connect to other
vertices that have a dissimilar degree.
2.5. DEGREE CENTRALITY PATHWAY ANALYSIS
We define the test statistic δ, as the average degree centrality in
the GRN, for a set of k genes defined by a Gene Ontology term.
For an undirected network, δ is given by,
δobs = 1
k
k∑
i= 1
( n∑
j= 1
Aij
)
, (7)
where A is again the adjacency matrix of the network.
For each gene set (resulting from a GO term), the null distri-
bution of δ is obtained from randomizations of the gene labels in
the GRN. The p-value is estimated from the fraction of random-
izations with a larger value than the test statistic, δobs, for a given
term in the GRN, i.e.,
p = P (δ ≥ δobs) . (8)
For each GO term, R = 10, 000 randomizations are performed.
We set the p-value to p = 0.0001 = 1/R in cases when none of
the randomizations exceed the test statistic for a given term.
We perform a multiple hypothesis correction using the FDR by
Benjamini and Hochberg (1995).
2.6. DRUGBANK
For the major hub genes in a GRN, we tabulated the associated
drugs from the drugbank database (Knox et al., 2011). We use
the drugbank version from july 2013. The drug to target protein
links were extracted from all_target_ids_all.csv and the drug-
names from drug_links.csv. We map uniprot identifiers to entrez
gene symbols using org.Hs.eg.db R-package (Carlson, 2013).
3. RESULTS
3.1. GLOBAL PROPERTIES OF GENE REGULATORY NETWORKS
For the B-cell lymphoma gene expression data set in Basso et al.
(2005), we infer 3 GRN using C3Net, BC3Net and Aracne. For
the 3 inferred networks, we estimated the edge-density, maximal
node degree, size of the giant component (GCC), assortativity
and transitivity (Table 1A). Here, the GCC is the largest sub-
network and its size corresponds to the number of genes in this
subnetwork.
As one can see from Table 1A, for these global measures
the networks differ considerably for all measures. Specifically,
the C3Net GRN has the lowest edge density (1.9 × 10−5) and
it is composed of 463 separated network components (sub-
networks). In contrast, the Aracne GRN has the highest edge
density (6.8 × 10−3) followed by the BC3Net GRN (1.2 × 10−3).
The assortativity coefficient shows a weak negative correla-
tion for C3Net indicating a tendency that, e.g., genes with
a high degree have a tendency to be connected with genes
with a low degree. For BC3Net and Aracne this cannot be
observed.
From a pairwise comparison of the 3 GRNs in Table 1B,
we find that the C3Net GRN is a subnetwork of BC3Net and
Aracne, with almost all edges (99%) represented in both net-
works (see Table 1B). Also the BC3Net and the Aracne GRN
show a large overlap with over 91.11% (52, 777/57, 905) of
common edges that are present in BC3Net. In contrast, only
16.46% (52, 777/320, 668) of the common edges are present in
the Aracne GRN.
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Table 1 | (A) Global network properties of the B-cell lymphoma C3Net,
BC3Net and Aracne GRN. (B) Edge-overlap between the 3 GRN.
C3Net BC3Net Aracne
(A)
Number of genes 9684 9684 9684
Number of edges 9221 57, 905 320, 668
Edge-density 1.9 × 10−5 1.2 × 10−3 6.8 × 10−3
Max degree 46 169 2198
Number of
components
463 8 1
Size of GCC 884 9668 9684
Assortativity −0.144 −0.0195 0.0543
Transitivity 0.089 0.000 0.230
(B)
C3Net 9221 (100%) 9215 (99.93%) 9167 (99.41%)
BC3Net 9215 (15.91%) 57, 905 (100%) 52, 777 (91.11%)
Aracne 9167 (2.86%) 52, 777 (16.46%) 320, 668 (100%)
(A, B) For this table, we compare the number of edges in both networks divided
by the total number of edges of the network in the row.
On a general note, we would like to add that the differing
number of edges in the 3 inferred GRN is related to the differ-
ent inference methods applied (see Methods section). Whereas
C3Net aims only to infer the interactions within a GRN that
are strongest, as emphasized by its name (Conservative Causal
Core = C3), BC3Net is a bagged (Breiman, 1996) version of
C3Net that is capable of exploiting also less strong signals by
estimating their variability from an ensemble approach. Finally,
Aracne employs an entirely different inference strategy than
C3Net or BC3Net.Whereas C3Net aims only to infer the strongest
interactions and BC3Net aims to add additional interactions
by bagging C3Net, Aracne uses the data processing inequality
to thinning all significant mutual information values. Hence,
C3Net is the most conservative approach, Aracne is the most
anti-conservative approach and BC3Net is situated in-between
them.
The results in Table 1 indicate clearly that the 3 GRNs are con-
siderably different among each other, if compared with global
measures.
3.2. FUNCTIONAL ANALYSIS OF B-CELL LYMPHOMA NETWORKS
Next, we investigate the functional similarity of the 3GRNs. In
order to identify the most prominently represented biological
processes in the 3 B-cell lymphoma GRN, we perform a gene
pair enrichment analysis (GPEA). The GPEA analysis tests the null
hypothesis whether the number of interactions in a GRN con-
necting genes from the same GO term is similar to the number
of interactions connecting genes from different GO terms. This is
tested by a hypergeometric test.
We perform the GPEA using gene sets, defined by the
Gene Ontology database, for the categories biological process
(BP), molecular function (MF) and cellular component (CC).
In addition, we use terms defined in the reactome database.
Furthermore, we compare the results obtained for the C3Net,
BC3Net and Aracne gene regulatory networks among each other.
Table 2 | (A) Functional enrichment using a GPEA for the C3Net,
BC3Net, and Aracne GRN. Shown are the numbers of significant
terms/number of total terms, and the percentage of significant
terms. (B) Overlap percentage (%) of significant terms in the GPEA
between the C3Net, BC3Net and Aracne gene regulatory networks.
C3Net% BC3Net% Aracne%
(A)
BP 124/1673 (7.4) 166/2604 (6.3) 386/3565 (10.8)
CC 30/241 (12.4) 49/357 (13.7) 110/477 (23.1)
MF 8/308 (2.6) 25/535 (4.7) 38/774 (4.9)
Reactome 92/270 (34.1) 129/387 (33.3) 186/492 (37.8)
(B)
C3Net vs.
BC3Net
92.74 96.67 87.50 96.74
C3Net vs.
Aracne
92.74 100.00 87.50 96.74
BC3Net vs.
Aracne
97.59 97.96 64.00 99.22
In Table 2A, we show an overview of the number of significant
terms identified using the GPEA. For example for GO BP, we find
124 significant terms for C3Net, 166 significant for BC3Net and
386 significant terms for Aracne. The number of significant terms
is similar between C3Net and BC3Net. For the Aracne GRN, the
number of significant terms is almost twice as large. The num-
ber of significant terms for the reactome is similar for all three
networks comprising a total of 30% of the terms. For MF the
number of significant terms is the lowest for the three networks
comprising only 5% of the terms. Table 2B shows the overlap of
significant terms for BP, MF, CC and reactome between C3Net,
BC3Net, and Aracne. For all pairwise comparisons, we observe
an overlap of >90% of significant terms between pairs of GRNs,
except for MF.
Another interesting observation we make is that the rank-
order of significant GO terms is highly correlated between C3Net
and BC3Net (r = 0.88, p ≤ 2.2 × 10−16), but also the other two
pairs of GRNs. For instance, Figure 2 shows a pairwise compari-
son of the rank-order of the GPEA analysis for BP terms between
BC3Net and Aracne, whereas the topmost 25 pairs are high-
lighted in blue. That means for each network, we rank-ordered
the analyzed GO terms according to their resulting p-values and
we used these ranks as x-coordinates (Aracne) and y-coordinates
(BC3Net) in Figure 2. On a technical note, we want to remark
that we used logarithmically transformed (log-transformed) val-
ues to obtain a better visualization of the shown GO terms.
However, because a logarithm is a monotonous function, the
original rank-order of the GO terms remains unchanged by this
transformation.
Biologically, from the top 25 BP GO terms in Figure 2 we
observe a variety of significant biological processes for pro-
tein translation, targeting and protein complex disassembly, viral
transcription and cell cycle. Interestingly, in contrast to the results
from the global analysis of GRNs, the functional analysis indicates
that all 3 GRNs are biologically quite similar to each other.
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FIGURE 2 | Comparison of the rank-order of significant biological process (BP) GO terms from the GPEA analysis for BC3Net (y-axis) and Aracne
(x-axis). The axis are log-transformed for a better visualization. The blue circles correspond to the top GO terms for Aracne and BC3Net.
3.3. EXPERIMENTAL INTERACTIONS: COMPARISONWITH REFERENCE
NETWORKS
In this section, we compare the 3 inferred GRNs with experimen-
tal networks (serving as reference networks). Specifically, we use a
protein-protein interaction network (PPN) and a transcriptional
regulatory network (TRN) for this comparison. The transcrip-
tional regulatory network is obtained from the HTRIdb database
of experimental validated transcription factor target gene inter-
actions (Bovolenta et al., 2012). The database comprises a total
of 284 transcription factors and 18, 302 target genes comprising a
total of 51, 871 interactions. The PPN is from iRefIndex contain-
ing a total of 185, 433 protein-protein interactions among 15, 233
proteins; see the Methods section for more details.
An overview of the pairwise comparisons between the B-cell
lymphomaGRNs and the TRN is shown inTable 3A and the com-
parison with the PPN is shown in Table 3B. The percentage of
shared interactions for all 3 GRNs is very low, and ranges around
0.1%. However, only for C3Net the number of shared interac-
tions with the TRN is significant. For the comparison between
the PPN and the inferred GRNs the number of shared interac-
tions is significant for all three GRNs and the percentage of shared
interactions is in the range between 1% to 2%. Again for C3Net
we observe the highest overlap of edges between the GRN and
the TRN.
3.3.1. Correlation between the degree centrality of the GRNs and
the reference networks
In this section, we study the correlation between the degree
centrality value of genes that we find in the GRNs and the exper-
imental reference networks, i.e., the TRN and the PPN, using the
Pearson correlation coefficient. Specifically, we start with the top-
most 25 genes in these networks and then increase the number
of the genes sequentially in step sizes of 25 genes, until all genes
are included. This corresponds to an averaging window with one
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fixed side and one sliding side that increases in steps of 25 genes
to lower ranked genes. The results of this analysis are shown in
Figure 3. In this figure, the gray area indicates correlation values
that would not be statistically significant for a significance level of
α = 0.05. In other words, all correlation values that are outside
the gray area, are statistically significant. We obtained the values
of the significance boundaries from using an assymtotic relation
between a t-statistic, t, and a Pearson correlation coefficient, r,
given by Sheskin (2004)
r = t√
df + t2 . (9)
Here df = n − 2 is the degree of freedom of the data for a pro-
file vector of length n. It is important to note that also a t-statistic
is a function of the degree of freedom, i.e., t(df ). From select-
ing a significance level α one obtains for each profile vector of a
certain length, n, the corresponding t-statistics, which gives via
Equation 9 the corresponding values for the Pearson correlation
coefficients. For our analysis we assumed a two-sided hypothesis
explaining the symmetric values of the correlation around zero.
As one can see from Figure 3, due to increasing sizes of the profile
vectors for which correlations are assessed, these decision bound-
aries are not constant but are becoming narrower around zero
when more genes are used in the analysis.
For all three GRNs and the PPN, we observe a tendency for the
high-degree genes to show a statistically significant negative cor-
relation to the degrees observed in the PPN (∼ −0.2, Figure 3A).
For larger window sizes, the correlation slowly decreases for
C3Net and BC3Net, but much faster for Aracne. Interestingly,
C3Net assumes positive statistically significant correlation val-
ues (∼0.05) for very large window sizes.The observations for
the comparison between the three GRNs and the TRN are sim-
ilar, however, less strong (see Figure 3B). In this case, all three
GRN inference methods C3Net, BC3Net and Aracne retain their
negative statistically significant correlation values, even for very
large window sizes.
Table 3 | Network comparison between the 3 B-cell lymphoma GRNs and the (A) TRN and (B) PPN.
(A) Transcriptional regulatory network (TRN)
Shared genes (%) Edges GRN Edges TRN Shared edges% p-value
C3Net 7915 6361 22,668 8 (0.125 ) 0.045
BC3Net 7915 39, 507 22, 668 33 (0.084) 0.176
Aracne 7915 210, 036 22, 668 134 (0.064) 0.923
(B) Protein protein network (PPN)
Shared genes (%) Edges GRN Edges PPN Shared edges% p-value
C3Net 7944 6429 100,074 145 (2.226) 0
BC3Net 7944 40,049 100,074 563 (1.406) 0
Aracne 7944 213,841 100,074 2110 (0.987) 0
Here, shared genes and shared edges correspond to the genes and edges that can be found in a GRN and the (A) TRN and (B) PPN.
A B
FIGURE 3 | Shown are Pearson correlation coefficients that are
obtained for genes that are rank-ordered according the size of
their degree centrality values in the GRNs compared to: (A)
PPN and (B) TRN. The ordering is from high to low degree
centrality values and the size of the underlying profile vectors
increases with the number of the gene rank. The gray area
indicates correlation values that are not statistically significant for
α = 0.05.
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3.4. HUB GENES
In this section, we study the major hub genes in the B-cell
lymphoma GRNs inferred from C3Net, BC3Net and Aracne.
Furthermore, we conduct a functional analysis to elucidate the
role of the involved biological processes of the major hub genes.
We start by performing a global comparison of the degree cen-
trality values for all genes between the C3Net, BC3Net and Aracne
GRN. The largest global rank-order Spearman correlation coeffi-
cient for all genes is observed between C3Net and BC3Net (r =
0.72, p < 2.2 × 10−16) and for BC3Net and Aracne (r = 0.74,
p < 2.2 × 10−16). The lowest correlation is observed between
C3Net and Aracne (r = 0.54, p < 2.2 × 10−16). In Figure 4,
we show the pairwise comparison between the rank-order of
the degree centrality of all genes for BC3Net and Aracne.
Interestingly, we observe no substantial difference between the
degree rank of genes with the highest node degree. This holds for
all pairwise comparisons between the three GRNs. That means all
3 GRNs contain essentially the same hub genes.
In general, the connection between hub genes for different
physiological contexts, as represented by a protein network (PPI)
or a GRN, is not well studied. In a PPI network, lethal pro-
teins have been observed to have the tendency to form hubs
(Jeong et al., 2001), whereas non-lethal disease associated pro-
teins, which are putative drug targets, are more likely to reside at
the periphery of a PPI network (Goh et al., 2007). Interestingly, in
contrast to a PPI network, the GRN hub genes of the B-cell lym-
phoma GRNs have the tendency to be associated with signaling
receptors, such as from the G-protein coupled receptor pathway
that comprises promising drug targets in cancer (Lappano and
Maggiolini, 2011).
We would like to note that the hub genes of the B-cell lym-
phoma GRNs, see Figure 4, are not restricted to signaling recep-
tors and can also include a variety of transcription factors such
as, e.g., ZIC2 and ELAVL2 (HuB). Although, the literature does
not show studies investigating these genes specifically for B-cell
lymphoma, several studies point to their importance for the
development of tumors. For instance, ZIC2 was observed with a
higher expression in malignant ovarian tumors (Marchini et al.,
2012) and overexpression analysis showed oncogenic properties
of ZIC2 to drive tumor growth in ovarian cancer (Marchini et al.,
2012). Also, proteins of the ELAV gene family (Hu genes) such as
ELAVL2 are tumor antigens that are investigated for early stage
lung cancer detection (D’Alessandro et al., 2010). Hu genes are
usually expressed in neuron cells and were found to have an
FIGURE 4 | Comparison of the rank-order of hub-genes for BC3Net (y-axis) and Aracne (x-axis). The axis are log-transformed for a better visualization. The
red circles correspond to the top hub genes for Aracne and BC3Net.
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Table 4 | Results for the degree centrality pathway analysis test for the BC3Net GRN.
GO Term δobs δ (avg) Size p-value FDR
GO:0007188 Adenylate cyclase-modulating G-protein
coupled receptor signaling pathway
17.5 11.95 86 0.0001 0.02877
GO:0007267 Cell-cell signaling 13.73 11.96 776 0.0001 0.02877
GO:0007600 Sensory perception 14.69 11.95 263 0.0001 0.02877
GO:0009581 Detection of external stimulus 21.06 11.95 52 0.0001 0.02877
GO:0009582 Detection of abiotic stimulus 21.77 11.96 47 0.0001 0.02877
GO:0009583 Detection of light stimulus 25.27 11.99 26 0.0001 0.02877
GO:0050877 Neurological system process 13.45 11.96 772 0.0001 0.02877
GO:0051320 S phase 16 11.95 119 0.0001 0.02877
GO:0007187 G-protein coupled receptor signaling pathway,
coupled to cyclic nucleotide second messenger
16.6 11.96 111 0.0001 0.02877
GO:0007601 Visual perception 16.24 11.97 132 0.0001 0.02877
GO:0008217 Regulation of blood pressure 15.92 11.97 110 0.0001 0.02877
GO:0050906 Detection of stimulus involved in sensory
perception
23.46 11.98 26 0.0001 0.02877
GO:0050953 Sensory perception of light stimulus 16.24 11.96 132 0.0001 0.02877
GO:0003073 Regulation of systemic arterial blood pressure 18.6 11.96 50 0.0002 0.04675
GO:0051606 Detection of stimulus 17.45 11.95 84 0.0002 0.04675
GO:0000216 M/G1 transition of mitotic cell cycle 17.85 11.95 65 0.0002 0.04675
GO:0007189 Adenylate cyclase-activating G-protein coupled
receptor signaling pathway
19.51 11.96 41 0.0003 0.06233
GO:0000084 S phase of mitotic cell cycle 15.96 11.96 113 0.0003 0.06233
GO:0045649 Regulation of macrophage differentiation 32 11.92 10 0.0004 0.07874
ectopic expression in neurodendocrine tumors (Gultekin et al.,
2000). However, the association between tumor progression and
Hu gene expression remains unclear on the molecular level.
For the functional analysis of the GRN hub genes, we applied
a non-parametric test to identify biological processes that are
related to genes with a large degree centrality value in the GRN.
We perform a permutation-based test that defines the average
degree centrality from the GRN as test statistic for the gene set
of a given GO term; see Equation 7. As a result, Table 4 shows
the most significant biological process terms with the highest
average degree centrality (δobs) in the GRN (with FDR≤0.1).
We observe a large variety of signaling related processes such
as adenylate cyclase-modulating G-protein coupled receptor sig-
naling pathway, cell-cell signaling, sensory perception, cell cycle
processes (S phase), blood pressure regulation and macrophage
differentiation.
We further studied whethermajor hub genes of a GRN are dru-
gable by known drugs that are related to the treatment of B-cell
lymphoma. For the 30 genes with the largest degree centrality in
the B-cell lymphoma BC3Net we extracted associated drugs from
the drugbank database (Knox et al., 2011). A variety of drugs
were associated with 8 genes comprising calcium-channel block-
ers (calcium channel subunit CACNA1F), dopamine antagonists
(serotonin receptor HTR7), metabolic compounds such as glu-
tathione, NADH, L-proline and pituitary hormone analogues, see
Table 5 for an overview.
3.4.1. MYC
The study of Basso et al. (2005) provided a validation for some
interactions of the transcription factor MYC. However, when
considering the degree centrality values of MYC in the inferred
networks, MYC has a low rank-order. Interestingly, this is con-
sistent for all three inferred GRNs and holds also for the ranking
of other network-based measures. In Table 6, the rank of MYC is
shown for C3Net, BC3Net and Aracne (in decreasing order of the
absolute degree value) for the degree centrality, betweenness and
local transitivity. For example, MYC ranks for the degree central-
ity of the GRN for C3Net 3110 (9684), BC3Net 9322 (9684) and
Aracne 2317 (9684). Here, the number in brackets corresponds
to the total number of genes. In the C3Net GRN, we find that
MYC has only one single direct neighbor. In the BC3Net GRN,
MYC has 4 direct neighbors, namely, POLD2 (52 neighbors),
NME1 (26 neighbors), SRM (30 neighbors), NINL (13 neighbors)
(Figure 5). For the Aracne GRN, MYC has 68 direct neighbors.
The direct neighbors of C3Net and BC3Net are also present in the
Aracne GRN.
4. DISCUSSION
In this paper, we conducted a structural and a functional analy-
sis of B-cell lymphoma GRNs that were inferred using 3 mutual
information-based inference methods, namely, C3Net (Altay and
Emmert-Streib, 2010), BC3Net (de Matos Simoes and Emmert-
Streib, 2012) and Aracne (Basso et al., 2005). On the global-level,
our analysis revealed that the inferred B-cell lymphoma GRNs
have major differences in their edge density, maximal degree,
transitivity and assortativity. However, on the edge-level, the 3
GRNs were highly similar among each other, whereas the C3Net
GRN and the BC3Net GRN represent almost a subnetwork of the
Aracne GRN. The global differences in the edge densities can be
mainly explained by the different inference strategies employed
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Table 5 | Drug targets for major hub genes in the BC3Net B-cell
lymphoma gene regulatory network, see Figure 4.
Target gene Drugbank Drugname
CACNA1F DB00393 Nimodipine
DB00568 Cinnarizine
DB00661 Verapamil
DB01388 Mibefradil
DB04855 Dronedarone
DB04920 Clevidipine
HTR7 DB00216 Eletriptan
DB00246 Ziprasidone
DB00247 Methysergide
DB00248 Cabergoline
DB00334 Olanzapine
DB00363 Clozapine
DB00751 Epinastine
DB01200 Bromocriptine
DB01224 Quetiapine
DB01238 Aripiprazole
DB04946 Iloperidone
DB06216 Asenapine
DB06288 Amisulpride
DB08815 Lurasidone
GSTM5 DB00143 Glutathione
TUB DB02028 DB02028
NR5A1 DB04683 DB04683
DB04752 Phosphatidyl ethanol
CYP4A11 DB00157 NADH
SLC6A7 DB00172 L-Proline
AVPR1B DB00035 Desmopressin
DB02638 Terlipressin
Table 6 | MYC rank (in decreasing order) for degree centrality,
betweeness and transitivity for the C3Net, BC3Net, and Aracne GRN.
GRN Degree rank Betweeness rank Transitivity rank
C3Net 3110 (1) 6955 (0) 1936 (0)
BC3Net 9322 (4) 2184 (4142.263) 3968 (0)
Aracne 2317 (68) 3397 (7778) 712 (0.23)
The absolute values of the centrality measure are shown in parenthesis. In total,
the maximal rank order is 9684 corresponding to the total number of genes.
by the three methods (see Methods section) resulting always
in GRNs with the following ordering in the number of edges;
#edgesC3Net < #edgesBC3Net < #edgesAracne.
A C3Net GRN represents the core network structure of a GRN
that considers only the strongest signal from a data set (Altay
and Emmert-Streib, 2010). Although C3Net limits the analysis
to a very sparse GRN structure, it provides a less complex and
more clearly arranged structural organization of large GRN net-
works (de Matos Simoes et al., 2012). Furthermore, because only
the strongest gene neighbors are considered for each gene, using
C3Net or BC3Net, the number of putative indirect associations is
highly reduced.
In our study, we compared also the biological functions that
are significantly represented in GRNs. We observed high similar-
ities between the GRN of C3Net, BC3Net and Aracne, where sig-
nificant biological processes, cellular components and Reactome
terms were overlapping with >90%. The tendency for Aracne to
observe a larger number of significant terms for the GPEA analysis
can be explained due to the larger edge-density that is beneficial
for a GPEA analysis. Among the significant terms common in all
3 GRNs, we find biological processes for protein translation, tar-
geting and protein complex disassembly, viral transcription and
cell cycle.
Next, we compared the 3 inferred GRNs with 2 experimental
networks (we called reference networks). Specifically, we com-
pared the 3 GRNs with a protein-protein interaction network
(PPN) and a transcriptional regulatory network (TRN). From
this comparison, we determined the quantitative edge-overlap
between the 2 reference networks and the 3 B-cell lymphoma
GRNs. For the TRN, we observed ∼ 0.1% of shared interactions
with the GRNs. However, for the PPN, we observed a higher
relative percentage of 1 − 2% of shared interactions. A reason
for this low, but significant (see p-values in Table 3), overlap is
three-fold. First, the used reference networks are not condition
specific for B-cell lymphoma. For instance, many interactions in
the PPN are obtained from yeast-two-hybrid (Y2H) experiments
providing only information about the potential binding of pro-
teins outside a particular cellular context (Maslov and Sneppen,
2002). Similarly, the experimentally verified interactions in the
TRN provided by the HTRidb database are identified from a wide
range of different normal (not pathological) physiological con-
ditions. Second, a GRN provides only an average representation
of the interactions across the spatial and temporal separation
of the cellular processes that are reflected by the observed gene
expression dependencies. Third, due to the different data types
used to assemble a PPN (e.g., Y2H), TRN (e.g., ChIP-chip)
and a GRN (gene expression) they are all different from each
other. The relation between these networks has been studied sys-
tematically for the model organisms S. cerevisiae and E.coli in
de Matos Simoes et al. (2013).
We compared the degree centrality of the GRNs to the PPN
and TRN. For the PPN and the TRN, we observed a statistically
significantnegative correlation for the geneswith the largest degree
centrality, independentof theGRNinferencemethod.Thatmeans,
themajor hub genes of a GRNhave a tendency to relate to proteins
with a low(er) degree in the PPN or TRN. This analysis suggest
that proteins with few direct neighbor interactions have a stronger
relationship in gene expression data for the corresponding genes
that are connected in a GRN, which may more likely represent the
periphery of the gene network. However, one major limitation of
defining the degree centrality from a PPN network is that protein
interactions are not well defined and gathered from multiple
experimental methods for different interaction types that are not
distinguished and largely incomplete.
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FIGURE 5 | BC3Net subnetwork including MYC (red) and its 2nd level nearest neighbors. The first degree MYC neighbors are shown in blue and the 2nd
degree MYC neighbors are shown in gray.
In a PPI network lethal proteins have been observed to have
a tendency to form hubs (Jeong et al., 2001), whereas non-lethal
disease associated proteins, which are putative drug targets, are
more likely to reside at the periphery of a PPI network (Goh
et al., 2007). Our functional analysis to identify pathways with
a significantly larger average degree centrality revealed pathways
involved in the G-protein coupled receptor signaling pathway,
sensory perception, cell-cell signaling and cell cycle. G-protein
coupled receptors are prominent drug targets for a large catalogue
of conditions such as cardiovascular related and neuropsychiatric
disorders (Esposito et al., 2002; Albizu et al., 2010) and promising
drug targets in cancer (Lappano and Maggiolini, 2011).
For example, the major hub gene CACNA1F, see Table 5, can
be inhibited by a variety of channel blockers like nifedipine,
amlodipine, verapamil, and diltiazem (Striessnig et al., 2010).
Due to the importance of ion channels in signaling the cal-
cium channel blockers are also being investigated for the treat-
ment of B-cell lymphoma (Shamash et al., 1998). For CACNA1F
6 calcium channel blocking drugs were identified from drug-
bank. The combination of verapamil and antineoplastic agents
is suggested to induce chemosensitivity in chemoresistant cells
(Simpson, 1985). Furthermore, mibefradil was shown to slow
tumor growth in glioblastoma cell lines (Keir et al., 2013).
The serotonin receptor HTR7 is a G-protein coupled recep-
tor. The drugs associated to HTR7 are dopamine antagonists
used for neuropsychiatric disorders. GSTM5 is associated to
Glutathione that is highly abundant and important for protect-
ing the cell against free radicals, but also promote chemore-
sistance (Balendiran et al., 2004). A number of studies inves-
tigated the depletion of Glutathione following chemotherapy
for increasing chemosensitization of cancer cells (Balendiran
et al., 2004). Lastly, AVPR1B is associated to desmopressin
which may impair metastasis of cancer cells (Gomez et al.,
2006).
The hub genes of the B-cell lymphoma GRN are not restricted
to signaling receptors and can also include transcription factors
such as ZIC2 or RNA-binding proteins such as ELAVL2 (HuB).
Although, the literature does not show studies investigating these
genes specifically for B-cell lymphoma several studies point to
their importance in tumorgenic processes. ZIC2 was observed
with higher expression in malignant ovarian tumors (Marchini
et al., 2012). Overexpression analysis showed oncogenic proper-
ties of ZIC2 to drive tumor growth in ovarian cancer (Marchini
et al., 2012). Proteins of the ELAV gene family (Hu genes) such
as ELAVL2 are tumor antigens that are investigated for early stage
lung cancer detection (D’Alessandro et al., 2010). Hu genes are
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usually expressed in neuron cells and were found to have an
ectopic expression in neurodendocrine tumors (Gultekin et al.,
2000). However, the association between tumor progression and
Hu gene expression remains unclear on the molecular level.
This discussion shows a potential application of the result-
ing GRNs. That means, major inferred hub genes could be used
for the experimental validation of drugs to effect important bio-
logical pathways of B-cell lymphoma. In this way, data-driven
hypothesis about drug targets could be derived from the inferred
GRN (Ildirim et al., 2007; Hopkins, 2008; Ghosh and Basu, 2012).
Additionally, in a similar way, hallmark pathways could be stud-
ied, because since the seminal work by Hanahan and Weinberg
(2000, 2011) it is generally accepted that the molecular causes of
cancer need to be approaches on this level, rather than on the level
of individual genes.
Overall, our analysis sheds light on the biological similarity
of GRNs inferred with C3Net, BC3Net and Aracne, and indi-
cates that these network inference methods contain consistent
biological information. This is a very important result, because
it demonstrates the biological robustness of the information that
can be reliably derived from such different GRNs, despite existing
differences among various other aspects of such networks.
4.1. DATA SHARING
We provide the gene expression data, the inferred GRNs and
the reference experimental networks from our analysis in the
R-package BClymphomaGRN, available from CRAN.
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